2015-11-04T14:51:38-06:00 2014-12-31 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE SUITE 4000 INDIANAPOLIS IN 46204 990 2014-01-01 912154267 Memorial Sloan-Kettering Cancer Center % MARK K SVENNINGSON MEMO 6462273092 1275 York Avenue New York NY 10065 MARK K SVENNINGSON SVP & CONTROLLER 6462273092 2015-11-04 true JENNIFER RHODERICK P00395735 3176817000 2014 2016-03-07 17:11:31Z CRAIG B THOMPSON MD 1275 York Avenue New York NY 10065 4230440145 true true 3475 X www.mskcc.org X LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION , AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. 113 93 16009 902 7302234 -10319990 538157930 545639247 2418623000 2624400000 285796000 211292557 143514942 220638228 3386091872 3601970032 56370000 59153000 0 0 1638636399 1731477540 1346005 1085777 58705475 1220593468 1377572715 2916945872 3169289032 469146000 432681000 8481418000 8977530000 3337444000 3612670000 5143974000 5364860000 X MEMORIAL SLOAN-KETTERING CANCER CENTER IS DEDICATED TO THIS MISSION: LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST-EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. LEADERSHIP IN PATIENT CARE WE PLACE THE HIGHEST PRIORITY ON ADVANCING THE CARE OF CANCER PATIENTS THROUGH EARLY DETECTION, ACCURATE DIAGNOSIS, AND OPTIMAL TREATMENT. THESE THREE ELEMENTS LEAD TO THE MOST EFFECTIVE CANCER CARE POSSIBLE, WHICH IS ALSO THE MOST COST-EFFECTIVE CARE POSSIBLE. WE STRIVE FOR EXCELLENCE IN ALL EXISTING AND EMERGING THERAPIES WITHOUT NEGLECTING THE NEED FOR ADVANCED APPROACHES IN PALLIATION. WE DELIVER THESE THERAPIES IN A CARING ENVIRONMENT THAT ENCOMPASSES PATIENTS AS WELL AS THEIR LOVED ONES. EXCELLENCE IN PATIENT CARE IS EXEMPLIFIED BY OUR MULTIDISCIPLINARY APPROACH, A CORE COMPETENCE OF OUR CENTER. WE ARE COMMITTED TO DEVELOPING OUTREACH PROGRAMS TO BRING EXCELLENCE IN CANCER CARE TO THE COMMUNITY. LEADERSHIP IN RESEARC false false 2481022529 34296000 2566972000 PATIENT CARE MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERTS HAVE ESTABLISHED STANDARDS OF CARE AND TREATMENT PROTOCOLS FOR EACH TYPE AND STAGE OF CANCER. OUR PHYSICIANS HAVE AN EXTRAORDINARY DEPTH AND BREADTH OF EXPERIENCE IN DIAGNOSING AND TREATING ALL FORMS OF THE DISEASE, FROM THE MOST COMMON TO THE VERY RARE. EACH YEAR, THEY TREAT MORE THAN 400 DIFFERENT SUBTYPES OF CANCER. THIS LEVEL OF SPECIALIZATION CAN HAVE AN OFTEN-DRAMATIC EFFECT ON A PATIENT'S CHANCES FOR A CURE OR CONTROL OF THEIR CANCER. WHILE WE ARE KNOWN FOR OUR ADVANCED, INNOVATIVE THERAPIES, OUR PHYSICIANS ARE EQUALLY WELL REGARDED FOR THEIR COMPASSION AND CONCERN. OUR DISEASE MANAGEMENT PROGRAM FEATURES 16 MULTIDISCIPLINARY CANCER TEAMS. PATIENTS ARE TREATED BY AS MANY DIFFERENT SPECIALISTS AS ARE NEEDED FOR THEIR PARTICULAR TYPE OF DISEASE, INCLUDING SURGEONS, MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, RADIOLOGISTS, PATHOLOGISTS, PSYCHIATRISTS, AND NURSES. OUR PATHOLOGISTS HAVE UNSURPASSED EXPERTISE IN USING ADVANCED METHODS TO ACCURATELY DIAGNOSE CANCER. BECAUSE OF THEIR SOLE FOCUS ON CANCER, OUR SURGEONS, USE SURGICAL TECHNIQUES THAT PRESERVE FORM AND FUNCTION. OUR RADIATION ONCOLOGISTS ARE DEVELOPING AND PUTTING INTO CLINICAL PRACTICE LEADING-EDGE TECHNOLOGIES AND TECHNIQUES IN RADIATION THERAPY. IN ADDITION, THE CENTER OFFERS A FULL RANGE OF PROGRAMS TO HELP PATIENTS AND FAMILIES THROUGHOUT ALL PHASES OF TREATMENT, INCLUDING SUPPORT GROUPS, GENETIC COUNSELING, HELP MANAGING CANCER PAIN AND SYMPTOMS, REHABILITATION, INTEGRATIVE MEDICINE SERVICES, AND ASSISTANCE IN NAVIGATING LIFE AFTER TREATMENT. 563550662 23854000 57428000 RESEARCH MEMORIAL SLOAN-KETTERING CANCER CENTER MAINTAINS ONE OF THE WORLD'S MOST DYNAMIC PROGRAMS OF CANCER RESEARCH. THE EXTRAORDINARY PATIENT CARE WE PROVIDE BENEFITS FROM OUR INNOVATIVE PROGRAMS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH. RESEARCH AT SLOAN-KETTERING INSTITUTE IS DEDICATED TO UNDERSTANDING THE BIOLOGY OF CANCER THROUGH PROGRAMS IN CELL BIOLOGY, GENETICS, BIOCHEMISTRY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, COMPUTATIONAL BIOLOGY, IMMUNOLOGY, AND THERAPEUTICS. INVESTIGATORS AT SLOAN-KETTERING INSTITUTE COLLABORATE WITH MEMORIAL HOSPITAL PHYSICIAN-SCIENTISTS, A PARTNERSHIP THAT HELPS SPEED IMPORTANT RESEARCH FINDINGS FROM THE LABORATORY TO THE BEDSIDE, IN A PROCESS KNOWN AS TRANSLATIONAL RESEARCH. MEMORIAL SLOAN-KETTERING CANCER CENTER ALSO ACTIVELY INITIATES AND PARTICIPATES IN CLINICAL TRIALS TO IDENTIFY MORE EFFECTIVE CANCER THERAPIES, AND OUR PHYSICIANS ARE CURRENTLY LEADING 735 CLINICAL TRIALS FOR PEDIATRIC AND ADULT CANCERS. THE HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM (HOPP) IS A FURTHER EFFORT TO INCREASE INSTITUTIONAL RESEARCH STRENGTH IN AREAS IMPORTANT IN CONTEMPORARY TRANSLATIONAL RESEARCH. HOPP IS DESIGNED TO MELD EVEN MORE THOROUGHLY THE CULTURES OF BASIC BIOLOGIC SCIENCE AND CLINICAL ONCOLOGY, AUGMENTING THE WORK CONDUCTED IN THE LABORATORIES OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S PHYSICIAN-SCIENTISTS. 3333809 1003000 GRADUATE SCHOOL OF BIOMEDICAL SCIENCE EDUCATION IS A VITAL PART OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S MISSION. OUR TRAINING PROGRAMS PREPARE PHYSICIANS AND SCIENTISTS FOR CAREERS IN THE BIOMEDICAL SCIENCES. OUR COLLABORATIONS WITH THE ROCKEFELLER UNIVERSITY, CORNELL UNIVERSITY, AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY OFFER PHD PROGRAMS IN CHEMICAL BIOLOGY, COMPUTATIONAL BIOLOGY AND MEDICINE, AND THE MEDICAL SCIENCES. THE CENTER ALSO PARTNERS WITH WEILL MEDICAL COLLEGE AND THE ROCKEFELLER UNIVERSITY TO OFFER A MD/PHD DEGREE FOR ASPIRING PHYSICIAN-SCIENTISTS. THE CENTER HAS A PHD PROGRAM IN CANCER BIOLOGY THROUGH ITS LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES. THIS NOVEL PROGRAM, HAS BEEN ENROLLING STUDENTS SINCE 2006, TRAINS BASIC LABORATORY SCIENTISTS TO WORK IN RESEARCH AREAS DIRECTLY RELEVANT TO CANCER AND OTHER HUMAN DISEASES. WE ALSO OFFER POSTGRADUATE CLINICAL FELLOWSHIPS TO TRAIN PHYSICIANS WHO SEEK SPECIAL EXPERTISE IN A PARTICULAR TYPE OF CANCER AND POSTGRADUATE RESEARCH FELLOWSHIPS THAT PROVIDE PHYSICIANS AND SCIENTISTS WITH ADVANCED LABORATORY RESEARCH TRAINING. WITH FACULTY APPOINTMENTS AT THE WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY, OUR CLINICAL STAFF ALSO TRAIN RESIDENTS AND MEDICAL STUDENTS. 3047907000 true true false true false false false false false true true true false false true false false true true false true false false true true false true true true true true true false false false false false true false true true false true false false false true true true true false false true 1437 0 true 16009 true true true false false false false true true false false false false X 113 93 false false false false true true false true true true false true true true true true true true true true true AK AZ AR FL GA IL KS LA MD MA MI MN MS MO NV NH NJ NM NY ND OH OK PA RI SC TN TX UT WA WI X X MARK K SVENNINGSON 6462273414 633 3RD AVENUE NEW YORK NY 10017 X RICHARD I BEATTIE SEE SCHEDULE O 2.0 0.0 X 0 0 0 ANTHONY B EVNIN SEE SCHEDULE O 2.0 0.0 X 0 0 0 STANLEY F DRUCKENMILLER SEE SCHEDULE O 1.0 0.0 X 0 0 0 RICHARD N FOSTER SEE SCHEDULE O 2.0 0.0 X 0 0 0 STEPHEN FRIEDMAN SEE SCHEDULE O 2.0 0.0 X 0 0 0 ELLEN V FUTTER SEE SCHEDULE O 1.0 0.0 X 0 0 0 PHILIP H GEIER JR SEE SCHEDULE O 1.0 0.0 X 0 0 0 LOUIS V GERSTNER JR SEE SCHEDULE O 2.0 0.0 X 0 0 0 JONATHAN N GRAYER SEE SCHEDULE O 1.0 0.0 X 0 0 0 JOHN R GUNN CHIEF OPERATING OFFICER 50.0 0.0 X X 1903399 0 89506 MICHAEL P GUTNICK EXECUTIVE VP & CFO 50.0 0.0 X X 1544206 0 85207 ANNETTE U RICKEL PHD SEE SCHEDULE O 2.0 0.0 X 0 0 0 BENJAMIN W HEINEMAN JR SEE SCHEDULE O 2.0 0.0 X 0 0 0 JEFFREY P JOHNSON SEE SCHEDULE O 1.0 0.0 X 0 0 0 VIRGINIA M ROMETTY SEE SCHEDULE O 2.0 0.0 X 0 0 0 DAVID H KOCH SEE SCHEDULE O 1.0 0.0 X 0 0 0 MARIE-JOSEE KRAVIS SEE SCHEDULE O 1.0 0.0 X 0 0 0 PETER J SOLOMON SEE SCHEDULE O 1.0 0.0 X 0 0 0 PETER A WEINBERG SEE SCHEDULE O 2.0 0.0 X 0 0 0 JAMES G NIVEN SEE SCHEDULE O 1.0 0.0 X 0 0 0 HUTHAM S OLAYAN SEE SCHEDULE O 1.0 0.0 X 0 0 0 BRUCE C RATNER SEE SCHEDULE O 1.0 0.0 X 0 0 0 CLIFTON S ROBBINS SEE SCHEDULE O 2.0 0.0 X X 0 0 0 JAMES D ROBINSON III SEE SCHEDULE O 1.0 0.0 X 0 0 0 BENJAMIN M ROSEN SEE SCHEDULE O 1.0 0.0 X 0 0 0 NORMAN C SELBY SEE SCHEDULE O 2.0 0.0 X X 0 0 0 STEPHEN C SHERRILL SEE SCHEDULE O 1.0 0.0 X 0 0 0 SCOTT M STUART SEE SCHEDULE O 1.0 0.0 X 0 0 0 MARK SVENNINGSON SVP FINANCE & CONTROLLER 50.0 0.0 X X 772427 0 77437 LUCY R WALETZKY MD SEE SCHEDULE O 1.0 0.0 X 0 0 0 DOUGLAS WARNER III SEE SCHEDULE O 4.0 0.0 X X 0 0 0 DEBORAH C WRIGHT SEE SCHEDULE O 2.0 0.0 X 0 0 0 SIMON N POWELL MD CHAIR & ATTEND RAD ONCOLOGY 50.0 0.0 X 1630580 0 70268 CRAIG B THOMPSON MD PRESIDENT & CEO 50.0 0.0 X X 2710645 0 234281 JOSE BASELGA MD PHD PIC & CHIEF MEDICAL OFFICER 50.0 0.0 X X 1644531 0 77103 WILLIAM E FORD SEE SCHEDULE O 2.0 0.0 X 0 0 0 JAMIE C NICHOLLS SEE SCHEDULE O 2.0 0.0 X 0 0 0 MARTHA VIETOR GLASS SEE SCHEDULE O 2.0 0.0 X 0 0 0 IAN COOK BOARD MEMBER EFFCTIVE 3/26/14 2.0 0.0 X 0 0 0 ERIC M COTTINGTON PHD SVP RESEARCH & TECHNOLOGY MGMT 50.0 0.0 X 783542 0 78402 JASON KLEIN SVP-CHIEF INVESTMENT OFFICER 50.0 0.0 X 1654126 0 855205 EDWARD MAHONEY SVP FACILITIES MGMT & CONST 50.0 0.0 X 786233 0 65340 KATHRYN MARTIN EVP & HOSPITAL ADMINISTRATOR 50.0 0.0 X 1503098 0 78609 RICHARD K NAUM SVP DEVELOPMENT 50.0 0.0 X 653909 0 69944 ROGER PARKER ESQ EVP & GENERAL COUNSEL 50.0 0.0 X 681672 0 50144 PATRICIA C SKARULIS SVP-CHIEF INFORMATION OFFICER 50.0 0.0 X 929835 0 52959 CAROLYN B LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 50.0 0.0 X 438693 0 44881 KERRY BESSEY SVP & CHIEF HR OFFICER 50.0 0.0 X 835793 0 76865 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 50.0 0.0 X 569369 0 48546 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 50.0 0.0 X 415214 0 51953 KENNETH MARIANS PHD DEAN, GERSTNER GRADUATE SCHOOL 50.0 0.0 X 541729 0 74723 GEORGE BOSL MD CHAIRMAN & ATTENDING MEDICINE 50.0 0.0 X 1038020 0 66804 HEDVIG HRICAK MD CHAIRMAN & ATTENDING RADIOLOGY 50.0 0.0 X 1480104 0 74515 ANNE MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 50.0 0.0 X 1247973 0 70306 PETER T SCARDINO MD CHAIRMAN & ATTENDING SURGERY 50.0 0.0 X 2067074 0 76406 RICHARD BARAKAT MD DPIC-REGIONAL CARE NETWORK 50.0 0.0 X 1367649 0 70891 PAUL SABBATINI MD DPIC CLINICAL RESEARCH 50.0 0.0 X 668600 0 46431 MICHELLE BURKE VP PATIENT SUPPORT SERVICES 50.0 0.0 X 368066 0 38711 ELIZABETH MCCORMICK MSNRN SVP & CH NURSING OFFICER 50.0 0.0 X 590501 0 56285 CYNTHIA MCCOLLUM SVP HOSPITAL OPERATIONS 50.0 0.0 X 588315 0 66978 MARGARET BURKE SVP AMBULATORY CARE-HOSP OPS 50.0 0.0 X 707154 0 73645 CHARLES LUCARELLI DIRECTOR PHARMACY 50.0 0.0 X 321476 0 57895 JOAN MASSAGUE PHD DIRECTOR, SLOAN KETTERING INST 50.0 0.0 X 772428 0 27703 PETER G CORDEIRO MD CH ATTDG PLASTIC & RECONST 50.0 0.0 X 1564065 0 71966 PHILIP GUTIN MD CHAIR & ATTENDING NEUROSURGERY 50.0 0.0 X 2739583 0 60754 JOSEPH DISA MD ATTENDING PLASTIC SURGERY 50.0 0.0 X 1567443 0 71344 MARK BILSKY MD ATTENDING-DEPT OF NEUROSURGERY 50.0 0.0 X 1795922 0 64296 DAVID JONES MD CHIEF ATTENDING THORACIC SURGY 50.0 0.0 X 1476553 0 64381 THOMAS KELLY MD LAB MEMBER. FORMER SKI DIR 50.0 0.0 X 909465 0 84370 ELLEN MILLER-SONET VP MARKETING 0.0 0.0 X 182945 0 29918 MAUREEN KILLACKEY DPIC MED DIR REGIONAL NETWORK 0.0 0.0 X 265161 0 9482 41717498 0 3364454 4212 true true false TURNER CONSTRUCTION 375 HUDSON STREET NEW YORK NY 10014 GENERAL CONSTRUCT. 131628476 JGN CONSTRUCTION CORP 66-40 69TH STREET MIDDLE VILLAGE NY 11379 GENERAL CONSTRUCT. 33395418 PERKINS EASTMAN ARCHITECTS 115 FIFTH AVENUE NEW YORK NY 10003 ARCHITECTURAL 10521896 HUNTER ROBERTS CONSTRUCTION GR LLC 2 WORLD FINANCIAL CENTER NEW YORK NY 10001 GENERAL CONSTRUCT. 36807269 MICHAEL ANTHONY CONTRACTING 161 RAILROAD AVE GARDEN CITY NY 11040 GENERAL CONSTRUCT. 5903852 149 644466 162698000 382296781 8996594 545639247 MEDICAL CARE 622310 2566972000 2566972000 NON-GOVERNMENT SPONSORED RESEARCH 541711 57428000 57428000 2624400000 33415557 -4330591 37746148 9811000 9811000 162710000 162710000 0 0 0 795614588 627548588 168066000 168066000 168066000 3027753 644466 921525 2106228 2106228 0 0 PARKING & STAFF HOUSING 722212 34542000 34542000 CAFETERIA 722212 4459000 4459000 VENDOR DISCOUNTS 561439 1003000 1003000 15818000 11632825 4185175 55822000 3601970032 2624400000 7302234 424628551 X 1000000 1000000 58153000 58153000 0 0 35604008 29476413 3825973 2301622 338403 338403 1288722465 1267047424 4923170 16751871 115016198 113263189 661751 1091258 211278770 202040349 5518698 3719723 80517696 78898697 537133 1081866 0 10565803 9099226 858180 608397 692687 544671 94849 53167 414936 414936 1085777 1085777 9867131 9867131 73067604 55687096 16357087 1023421 7228415 584690 1548127 5095598 229609263 205675484 883934 23049845 18545532 18418518 47453 79561 8168773 8168773 105569090 96232899 8337231 998960 10096075 9200639 223168 672268 0 12248261 11001297 374316 872648 50147024 49375043 771981 0 217342484 211873431 4681738 787315 23594661 15765909 7821217 7535 PHARMACEUTICALS 401400549 401400549 MEDICAL/SURGICAL SUPPLIES 164078998 163809565 269433 PROVISION BAD DEBT-REG ASSMT 35874251 35744615 69400 60236 UBIT EXPENSE -17297 -17297 -921525 12860957 -13146889 -635593 3169289032 3047907000 62676557 58705475 X 18679114 8604482 10074632 213478000 240996000 366501000 349020000 574243000 694478000 411312000 471570000 1600000 1400000 0 0 28029000 28497000 39450000 41937000 99967000 97145000 4679319000 2178005000 2228299000 2501314000 3685090000 3631578000 830153000 915993000 3296000 3602000 0 0 0 0 8481418000 8977530000 503569000 597522000 0 0 0 0 1252891000 1198549000 0 0 0 0 0 0 845140000 845140000 735844000 971459000 3337444000 3612670000 X 3932443000 4011535000 656237000 765065000 555294000 588260000 5143974000 5364860000 8481418000 8977530000 X 432681000 49902000 -261697000 X false true X true true true X 3 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 131624182 04 true 0 0 MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASES 131624082 03 true 0 0 MEMORIAL SLOAN-KETTERING CANCER CENTER 131924236 03 true 0 0 3 0 398129000 463933000 386914750 537706930 544924247 2331607927 0 0 398129000 463933000 386914750 537706930 544924247 2331607927 132535194 2199072733 98781000 121135584 122928000 132845000 206274557 681964141 0 1181000 1464000 3157250 2843070 3027753 11673073 3025245141 11532953511 0.72691 0.67741 X 0.00000 true false false false false false false false false false false false false false false true false false false false 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SUPPORTED ORGANIZATIONS SUPPORT FROM THE SUPPORTING ORGANIZATIONS RELATE PRINCIPALLY TO THE SUPPORTING ORGANIZATIONS NAME OF SUPPORTING ORGANIZATION EIN TYPE RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false true false false false false true 157368 false true 257568 414936 false LOBBYING COSTS MSKCC ENGAGES IN BOTH FEDERAL AND STATE LOBBYING. THE CENTER'S FEDERAL LOBBYING EFFORT FOCUSES ON PATIENT CARE AND REIMBURSEMENT ISSUES. PATIENT CARE ADVOCACY INCLUDES ENSURING PATIENTS ARE ABLE TO ACCESS CLINICAL TRIALS AND CANCER HOSPITALS ARE ABLE TO EFFECTIVELY RESEARCH POTENTIAL TREATMENTS FOR CANCER AS WELL AS PREVENTIVE AND PALLIATIVE MEASURES. THE CENTER ALSO SEEKS TO RECEIVE EQUITABLE REIMBURSEMENT FOR SERVICES RENDERED TO PATIENTS ENROLLED IN ENTITLEMENT PROGRAMS. FROM TIME TO TIME THE CENTER WEIGHS IN ON OTHER FEDERAL LEGISLATION THAT IMPACTS CANCER CARE AND HOSPITALS IN GENERAL. THE CENTER'S STATE LOBBYING EFFORT CONCENTRATES ON LEGISLATION THAT IMPACTS PROVIDERS' ABILITIES TO EFFECTIVELY CARE FOR PATIENTS, SUCH AS LEGISLATION THAT AMENDS CONSTRUCTION REVIEW PROCEDURES, PROVIDES FUNDING FOR BLOOD DONATION DRIVES, OR ENCOURAGES COLLABORATION BETWEEN CARE PROVIDERS AT HOSPITAL FACILITIES. STATE EFFORTS ALSO FOCUS ON ADVOCATING FOR HEALTH CARE ISSUES DURING STATE BUDGET NEGOTIATIONS. LOCAL LOBBYING IS PERFORMED BY THE GREATER NEW YORK HOSPITAL ASSOCIATION ON BEHALF OF ITS MEMBERS. PART II-B LINE 1I OTHER ACTIVIES LOBBYING PORTION OF DUES PAID IN 2014: AMERICAN HOSPITAL ASSOCIATION $ 29,180 GREATER NEW YORK HOSPITAL ASSOCIATION $228,388 TOTAL $257,568 false false 753249000 25760000 9616000 15885000 772740000 709754000 56687000 44303000 57495000 753249000 726867000 24401000 10195000 51709000 709754000 748997000 32670524 -2933000 51867524 726867000 767701000 13421000 9453000 41578000 748997000 0.23870 0.76130 false false 136470000 136470000 3280522000 1268336000 2012186000 112649000 53018000 59631000 1149678000 856651000 293027000 2501314000 PRIVATE EQUITY & VENTURE CAP. 830114000 F NONMARKETABLE SECURITIES 85879000 C 915993000 0 PENSION AND POSTRETIREMENT 593451000 INSURANCE RESERVES 251066000 DEFERRED COMPENSATION 58122000 ASSET RETIREMENT OBLIGATIONS 35020000 DEFERRED GIFT ANNUITY 24735000 OTHER LIABILITIES 9065000 971459000 3632009000 49902000 921525 50823525 3581185475 20784557 20784557 3601970032 3148426000 921525 921525 3147504475 20784557 1000000 21784557 3169289032 USE OF ENDOWMENT FUNDS PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. OTHER OTHER-PARTS XI AND XII $921,525 ARE DIRECT EXPENSES RELATING TO FUNDRAISING EVENTS. COSTS ARE REMOVED FROM THE STATEMENT OF FUNCTIONAL EXPENSES AND NETTED ON THE STATEMENT OF REVENUE. PART XII OTHER 4B- PAYMENT OF A GRANT TO THE RALPH LAUREN CENTER FOR $1,000,000 RECORDED AS NON OPERATING EXPENSE. FIN 48 LIABILITY FOR UNCERTAIN TAX POSITIONS A FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS. true true true true true true false false false false false false false false false false true NONDISCRIMINATORY POLICY THE SCHOOL'S NONDISCRIMINATORY POLICY IS PUBLICIZED ON ITS WEB SITE. HTTP://WWW.SLOANKETTERING.EDU/GERSTNER/HTML/54499.CFM ALL APPLICANTS TO THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES ARE CONSIDERED ON THE BASIS OF MERIT. THE SCHOOL DOES NOT DISCRIMINATE ON THE BASIS OF GENDER, RACE, COLOR, CREED, RELIGION, AGE, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS, MARITAL STATUS, SEXUAL ORIENTATION, OR CITIZENSHIP STATUS IN ACCORDANCE WITH INSTITUTIONAL POLICY AND IN COMPLIANCE WITH THE REQUIREMENTS OF THE CIVIL RIGHTS ACT, THE EDUCATION ADMENDMENTS, THE REHABILITATION ACT, THE AGE DISCRIMINATION ACT, AND THE AMERICANS WITH DISABILITIES ACT. Central America and the Caribbean Investments 1099317790 Europe (Including Iceland and Greenland) Investments 92687108 Central America and the Caribbean Program Services PATIENT CARE CONFERENC 12878 East Asia and the Pacific Program Services PATIENT CARE CONFERENC 164789 Europe (Including Iceland and Greenland) Program Services PATIENT CARE CONFERENC 544363 Middle East and North Africa Program Services PATIENT CARE CONFERENC 36442 North America Program Services PATIENT CARE CONFERENC 52967 Russia and the Newly Independent States Program Services PATIENT CARE CONFERENC 1598 South America Program Services PATIENT CARE CONFERENC 46718 South Asia Program Services PATIENT CARE CONFERENC 16047 Sub-Saharan Africa Program Services PATIENT CARE CONFERENC 35767 Central America and the Caribbean Program Services RESEARCH CONFERENCES 6267 East Asia and the Pacific Program Services RESEARCH CONFERENCES 142005 Europe (Including Iceland and Greenland) Program Services RESEARCH CONFERENCES 461910 Middle East and North Africa Program Services RESEARCH CONFERENCES 22023 North America Program Services RESEARCH CONFERENCES 68848 South America Program Services RESEARCH CONFERENCES 3417 South Asia Program Services RESEARCH CONFERENCES 14227 East Asia and the Pacific Program Services EDUCATIONAL CONFERENCE 1588 Europe (Including Iceland and Greenland) Program Services EDUCATIONAL CONFERENCE 4576 North America Program Services EDUCATIONAL CONFERENCE 1014 South America Program Services EDUCATIONAL CONFERENCE 1000 Sub-Saharan Africa Program Services EDUCATIONAL CONFERENCE 13303 East Asia and the Pacific Program Services INVESTMENT MEETINGS 11648 Europe (Including Iceland and Greenland) Program Services INVESTMENT MEETINGS 47689 North America Program Services INVESTMENT MEETINGS 1232 South Asia Program Services INVESTMENT MEETINGS 1754 1193620937 98031 1193718968 true false true true true false ORGANIZATION'S PROCEDURES FOR THE USE OF FUNDS OUTSIDE THE US MEMORIAL SLOAN-KETTERING CANCER CENTER DOES NOT MAKE GRANTS OR USE GRANT MONEY OUTSIDE OF THE UNITED STATES. INVESTMENTS BY REGION VALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31. X X X X X X X true TARGET MARKETEAM DIRECT MAIL CONSULTING false 10378020 486000 9892020 DONOR SERVICES TELEMARKETI CONSULTING false 6333582 296600 6036982 Paradysz Matera Co Mail list consulting false 3851505 180365 3671140 M R STRATEGIC SERVICES TELEMARKETI CONSULTING false 2622521 122812 2499709 23185628 1085777 22099851 All States SPRING BALL 1293985 134660 1159325 133662 32026 124867 FALL PARTY 647150 5967 641183 102000 5000 42173 5 1731084 503839 1227245 112070 184883 24670 160174 3672219 644466 3027753 214070 318545 61696 327214 921525 2106228 true true X true X 500. true X 500. true true true false true true 16724811 7702354 9022457 0.00290 123670531 56066054 67604477 0.02150 140395342 63768408 76626934 0.02440 18103202 306500 17796702 0.00570 178304950 11155109 167149841 0.05310 3124615 34500 3090115 0.00100 428969429 170491000 258478429 0.08220 1204656 90250 1114406 0.00040 629706852 182077359 447629493 0.14240 770102194 245845767 524256427 0.16680 2261 2261 156935 90000 66935 426495 132386 294109 0.00010 115320 83000 32320 196167 196167 0.00010 897178 305386 591792 0.00020 false 30253356 1704389 648761327 794858446 -146097119 X true true 1 1 MEMORIAL HOSP FOR CANCER & ALLIED DIS 1275 YORK AVENUE NEW YORK NY 10065 www.mskcc.org 7002020H X X X X MEMORIAL HOSP FOR CANCER & ALLIED DIS 1 false false true X X X X X X X X X 13 true false false true X https://www.mskcc.org/communityservicepl X true 13 true www.mskcc.org false false true X 500. 500. X X X X X X true true X X X X X true X X X X X X X X X X true X false X X false X X false false SCHEDULE H FACILITY INFORMATION PART V - FACILITY INFORMATION SECTION C. SUPPLEMENTAL INFORMATION FOR PART V, SECTION B. LINE 5 FROM JANUARY TO APRIL 2013, WE CONDUCTED AN ONLINE SURVEY OF COMMUNITY MEMBERS, PATIENTS, HEALTHCARE CONSUMERS AND CONSUMER ADVOCATES, NONPROFIT AND COMMUNITY-BASED ORGANIZATIONS, AND HEALTHCARE PROVIDERS TO GATHER PRIMARY INPUT ON THE NEED FOR CANCER CARE AND TREATMENT SERVICES IN THE COMMUNITY. WE RECEIVED NEARLY 1,500 COMPLETED SURVEY RESPONSES AS A RESULT OF OUR OUTREACH EFFORTS. MSK STAFF MEMBERS CONSISTENTLY COLLABORATE WITH A WIDE RANGE OF COMMUNITY CONTACTS IN ORDER TO BETTER UNDERSTAND THE BROAD INTERESTS AND HEALTH NEEDS OF THE COMMUNITY IDENTIFIED WITHIN OUR SERVICE AREA. WE REGULARLY CONSULT WITH REPRESENTATIVES FROM NUMEROUS ORGANIZATIONS, INCLUDING THE FOLLOWING: AFYA FOUNDATION AMERICAN CANCER SOCIETY ARAB AMERICAN COMMUNITY TASK FORCE THE BROOKLYN CENTER FOR HEALTH DISPARITIES, SUNY DOWNSTATE SCHOOL OF MEDICINE CENTER TO REDUCE CANCER DISPARITIES, NATIONAL CANCER INSTITUTE THE CITY COLLEGE OF NEW YORK COMMUNITY HEALTH WORKER NETWORK OF NYC GAY MEN'S HEALTH CRISIS HEALTH LITERACY RESOURCE CENTER, LITERACY ASSISTANCE CENTER LEUKEMIA & LYMPHOMA SOCIETY MEXICAN CONSULATE COALITION NEW YORK CITY C5 COLORECTAL CANCER INITIATIVE STEERING COMMITTEE NEW YORK CITY DEPARTMENT OF EDUCATION NEW YORK CITY DEPARTMENT OF HEALTH & MENTAL HYGIENE NEW YORK IMMIGRATION COALITION NEW YORK LANGUAGE ASSISTANCE WORKING GROUP NEW YORK LAWYERS IN THE PUBLIC INTEREST NEW YORK STATE DEPARTMENT OF HEALTH NEW YORK STATE NATIONAL MINORITY HEALTH COUNCIL QUEENS CANCER CENTER RALPH LAUREN CENTER FOR CANCER CARE AND PREVENTION SHINNECOCK RESERVATION SOUTH ASIAN COUNCIL ON SOCIAL SERVICES SOLVING KIDS CANCER INC. LINE 7D SUMMARY FINDINGS OF MSK'S CHNA WERE INCORPORATED INTO OUR ANNUAL COMMUNITY SERVICE PLAN REPORT. THE COMMUNITY SERVICE PLAN (CSP) IS MAILED TO LOCAL ELECTED OFFICIALS AND ORGANIZATIONS, AND IS PUBLICIZED THROUGH OUR COMMUNITY NEWSLETTER WHICH IS MAILED TO 80,000+ RESIDENTS NEAR OUR TREATMENT FACILITIES. THE CSP PROVIDES DIRECTION ON HOW TO ACCESS THE FULL NEEDS ASSESSMENT RESULTS ON OUR WEBSITE AND IS AVAILABLE TO THE PUBLIC AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. LINE 11 EACH YEAR MSK PUBLISHES A COMMUNITY SERVICE PLAN UPDATE THAT DETAILS HOW WE ARE ADDRESSING THE SIGNIFICANT NEEDS IDENTIFIED IN THE MOST RECENTLY CONDUCTED CHNA. AS NOTED IN THE RESPONSE TO LINE 7D ABOVE, THE CSP IS MADE WIDELY AVAILABLE TO THE PUBLIC THROUGH A VARIETY OF MECHANISMS INCLUDING ON OUR WEBSITE AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. INFORMATION ON IDENTIFIED NEEDS AND WHAT NEEDS ARE NOT BEING ADDRESSED TOGETHER WITH THE REASON WHY SUCH NEEDS ARE NOT BEING ADDRESSED CAN BE FOUND ON THAT SAME PAGE IN THE HOSPITAL'S MOST RECENT COMPREHENSIVE THREE-YEAR CSP AND CHNA REPORT. IDENTIFIED NEEDS THAT MSK CANNOT ADDRESS ADEQUATELY BECAUSE THEY ARE SUBJECT TO NEW YORK CITY MARKET CONDITIONS AND EXTERNAL AGENCY CONTROL ARE: FACILITATE AFFORDABLE, PATIENT-FRIENDLY, AND CONVENIENT PUBLIC TRANSPORTATION TO OUR FACILITIES FROM REGIONAL LOCATIONS AND THE OUTER BOROUGHS; AND IDENTIFY ADDITIONAL AFFORDABLE HOUSING FOR PATIENTS AND THEIR FAMILIES NEAR OUR MAIN CAMPUS DURING TREATMENT. WITHIN THESE CONSTRAINTS, MSK PROVIDES TRANSPORTATION AND HOUSING ASSISTANCE TO PATIENTS AND THEIR FAMILIES ON AN AS-NEEDED BASIS. MSK'S SOCIAL WORK DEPARTMENT PROVIDES REFERRALS TO DISCOUNTED HOTEL ROOMS OR OTHER LODGING OPTIONS TO PATIENTS UPON REQUEST. LIMITED PHILANTHROPIC FUNDS ARE AVAILABLE FOR ELIGIBLE PATIENTS WHO MEET CRITERIA. TO ASSIST WITH TRANSPORTATION, MSK OPERATES SEVERAL JITNEYS TO TRANSPORT PATIENTS BETWEEN SITES AND NEGOTIATES REDUCED PARKING FEES AT GARAGES NEAR OUR SITES. OUR STAFF ALSO HELPS OUR PATIENTS TO COMPLETE A NEW YORK CITY ACCESS-A-RIDE PROGRAM APPLICATION FOR TRANSPORTATION ASSISTANCE FOR MEDICALLY ELIGIBLE PATIENTS. ELIGIBLE PATIENTS IN NEED ALSO HAVE ACCESS TO METRO CARDS TO COVER BUS AND SUBWAY FARE, PHILANTHROPIC FUNDS FOR TRANSPORTATION, AND REFERRALS TO COMMUNITY-BASED ORGANIZATIONS THAT OFFER FUNDS TOWARDS PATIENT OUT-OF POCKET COSTS. MANY TRAVEL, PARKING, AND ACCOMMODATION RESOURCES ARE LISTED ON OUR WEBSITE AT WWW.MSKCC.ORG/CANCER-CARE/HOSPITAL-INFORMATION. Line 13E NEW PATIENTS WHO RESIDE IN NEW YORK OR NEW JERSEY MAY QUALIFY FOR AID. EXISTING MEMORIAL HOSPITAL PATIENTS MAY QUALIFY FOR AID REGARDLESS OF WHERE THEY LIVE IN THE UNITED STATES LINE 15E FOR MANY YEARS MSKCC HAS PROVIDED FINANCIAL HELP TO PATIENTS IN NEED. OUR FINANCIAL ASSISTANCE PROGRAM HELPS UNINSURED AND UNDERINSURED PATIENTS WITH HOUSEHOLD INCOME UP TO FIVE TIMES THE FEDERAL POVERTY LEVEL WHO CANNOT GET PUBLICLY FUNDED HEALTH INSURANCE OR CANNOT AFFORD TO PAY FOR THEIR MEDICAL CARE. PATIENTS ARE EDUCATED ABOUT THE FINANCIAL ASSISTANCE PROGRAM - ELIGIBILITY CRITERIA, THE APPLICATION PROCESS ETC. TO BE CONSIDERED FOR THE FINANCIAL ASSISTANCE PROGRAM, PATIENTS ARE ASKED TO PROVIDE CERTAIN PERTINENT DOCUMENTATION TO ASSIST IN DETERMINING THEIR ELIGIBILITY AND THE AMOUNT OF FINANCIAL ASSISTANCE THEY ARE QUALIFIED TO RECEIVE. TO FURTHER ENHANCE THE PROCESS, WE STRATEGICALLY PLACE FINANCIAL ASSISTANCE BROCHURES AT EACH REGISTRATION SITE AND AT THE FRONT DESK OF THE PATIENT FINANCIAL SERVICES OFFICE. WE INCLUDE COPIES WITH THE FIRST HOSPITAL BILL SENT TO PATIENTS AND WITH COLLECTION LETTERS MAILED OUT TO THEM. FURTHERMORE, THE FINANCIAL ASSISTANCE INFORMATION IS POSTED ON THE MSKCC WEBSITE AS WELL. LINE 20E EVERY HOSPITAL STATEMENT AND COLLECTION LETTER REFERENCES OUR FINANCIAL ASSISTANCE PROGRAM AND WHO TO CALL WHEN EXPERIENCING FINANCIAL DIFFICULTY. LINE 21D ALL OF OUR PATIENTS REQUIRING URGENT CARE ARE ABLE TO RECEIVE IT REGARDLESS OF THEIR INSURANCE RESTRAINTS OR EVEN IF IT HAS NOT BEEN DETERMINED THAT THE PATIENT IS ELIGIBLE FOR MSKCC'S FINANCIAL ASSISTANCE PROGRAM LINE 22 AN INDIVIDUAL WHO IS DETERMINED TO BE ELIGIBLE FOR FAP WILL NEVER BE CHARGED MORE FOR MEDICALLY NECESSARY CARE THAN THE AMOUNTS GENERALLY BILLED TO INDIVIDUALS WHO HAVE INSURANCE THAT COVERS 80 PERCENT OF THE TOTAL Charges 16 LAURANCE S ROCKEFELLER OP PAVILION 160 EAST 53RD STREET NEW YORK NY 10065 EXTENSION CLINIC BREAST AND IMAGING CENTER 300 EAST 66TH STREET NEW YORK NY 10065 EXTENSION CLINIC MSKCC COMMACK 650 COMMACK ROAD COMMACK NY 11725 EXTENSION CLINIC MSKCC BASKING RIDGE-AMBULATORY CARE 136 MOUNTAIN VIEW BLVD BASKING RIDGE NJ 07920 EXTENSION CLINIC SIDNEY KIMMEL PROSTATE & UROLOGIC CENTER 353 EAST 68TH STREET NEW YORK NY 10065 EXTENSION CLINIC MSKCC SLEEPY HOLLOW 777 NORTH BROADWAY SLEEPY HOLLOW NY 10591 EXTENSION CLINIC MSKCC HAUPPAUGE 800 VETERANS MEMORIAL HIGHWAY HAUPPAUGE NY 11787 EXTENSION CLINIC MSKCC ATLANTIC AVENUE CENTER 557 ATLANTIC AVENUE BROOKLYN NY 11217 EXTENSION CLINIC MSKCC COUNSELING CENTER 641 LEXINGTON AVENUE NEW YORK NY 10065 EXTENSION CLINIC MSKCC OP IMAGING AT EAST 55 STREET 301 EAST 55TH STREET NEW YORK NY 10065 EXTENSION CLINIC POST TREATMENT RESOURCES PROGRAM 215 EAST 68TH STREET NEW YORK NY 10065 EXTENSION CLINIC THE BENDHEIM INTEGRATIVE MEDICINE CENTER 1429 FIRST AVENUE NEW YORK NY 10021 EXTENSION CLINIC THE HARLEM BREAST EXAMINATION CENTER 163 WEST 125TH STREET NEW YORK NY 10065 EXTENSION CLINIC MSKCC - 64TH STREET 205 EAST 64TH STREET NEW YORK NY 10065 EXTENSION CLINIC SILLERMAN CENTER FOR REHABILIATION 515 MADISON AVENUE NEW YORK NY 10022 EXTENSION CLINIC MSKCC WEST HARRISON 500 WESTCHESTER AVENUE WEST HARRISON NY 10604 EXTENSION CLINIC SCHEDULE H PART VI SUPPLEMENTAL INFORMATION PART 1, LINE 3C: A PATIENT WITH INCOME LESS THAN OR EQUAL TO 500% OF THE FPL IS ELIGIBLE FOR THE INSTITUTION'S FINANCIAL ASSISTANCE PROGRAM. FOR INSTANCE, THE INSTITUTION MAY REDUCE THE FEES INCURRED BY THE PATIENT OR ACCEPT AS FULL PAYMENT AMOUNTS PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. THIS IS BECAUSE THE INSTITUTION ADJUSTS PATIENTS' INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE DISPOSABLE INCOME. MSKCC ALSO DEDUCTS A SPECIFIC AMOUNT (DEBT BURDEN) AS A MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENT'S FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. FAMILY ALLOWED RESOURCE FOOD & CLOTHING SIZE INCOME LEVELS ALLOWANCE 1 $58,350 $33,096 $1,147 2 $78,650 $40,734 $1,431 3 $98,950 $48,372 $1,641 4 $119,250 $56,012 $1,859 5 $139,550 $63,650 $2,062 6 $159,850 $71,288 $2,279 PART I, LINE 7G: MEMORIAL SLOAN KETTERING CANCER CENTER HAS CONSISTENTLY SET THE STANDARD OF CARE FOR PEOPLE WITH CANCER BY EMPHASIZING EARLY DETECTION, PRECISE DIAGNOSIS, AND INDIVIDUALLY TAILORED TREATMENT. THE HOSPITAL SUBSIDIZES CANCER SCREENING, TREATMENT, AND SUPPORT SERVICES TO FULFILL ITS MISSION AND TO HELP REDUCE CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. MSKCC'S BREAST EXAMINATION CENTER OF HARLEM (BECH) PROVIDES BREAST AND CERVICAL CANCER SCREENING, COUNSELING AND PATIENT FOLLOW-UP, AS WELL AS EDUCATIONAL PROGRAMS TO UNINSURED PATIENTS THROUGHOUT THE NEW YORK CITY AREA. BECH HAS A DEDICATED STAFF, INCLUDING A HEALTH EDUCATOR WHOSE ROLE IS TO INITIATE AND IMPLEMENT OUTREACH ACTIVITIES IN HARLEM AND THE SURROUNDING COMMUNITIES. SINCE ITS INCEPTION IN 1979, BECH HAS HAD MORE THAN 236,546 VISITS, WITH 3,176 OF THOSE VISITS TAKING PLACE IN 2014. ALL SERVICES WERE PROVIDED AT NO OUT-OF-POCKET EXPENSE TO THE WOMEN WHO RECEIVED CANCER SCREENING AND FOLLOW-UP SERVICES. LOCATED IN HARLEM, THE RALPH LAUREN CENTER FOR CANCER CARE AND PREVENTION (RLCCCP) OFFERS CANCER SCREENING AND TREATMENT SERVICES TO ITS MEDICALLY UNDERSERVED COMMUNITY. THE RLCCCP, MADE POSSIBLE IN PART THROUGH A GIFT FROM THE POLO RALPH LAUREN CORPORATION, IS SOLELY OWNED BY MSKCC. SINCE ITS INCEPTION RLCCCP HAS CONDUCTED MORE THAN 116,000 VISITS, OF WHICH APPROXIMATELY 11,000 OCCURRED IN 2014. RLCCCP CONTINUES TO PROVIDE CARE TO INDIVIDUALS ON MEDICAID AND MEDICAID MANAGED CARE PROGRAMS. TO BETTER SERVE THE NEEDS OF DIAGNOSED PATIENTS, THE RALPH LAUREN CENTER HAS EXPANDED ITS NAVIGATION EFFORTS BY CREATING A MULTIDISCIPLINARY TEAM FOR EACH ONCOLOGIST, CONSISTING OF A CLINICAL NURSE NAVIGATOR AND LAY NAVIGATOR. BOTH NAVIGATORS ASSIST PATIENTS FROM THE TIME OF DIAGNOSIS TO COMPLETION OF TREATMENT AND BEYOND. THE CLINICAL NAVIGATOR FOCUSES ON MEDICAL ISSUES, WORKING WITH THE ONCOLOGIST TO ENSURE THAT THE PATIENT UNDERSTANDS THEIR DIAGNOSIS AND TREATMENT PLAN. THE LAY NAVIGATOR WORKS WITH THE PATIENT TO ELIMINATE BARRIERS SUCH AS TRANSPORTATION AND LINKING PATIENT TO SERVICES IN THE COMMUNITY AS DEEMED NECESSARY. MEMORIAL SLOAN KETTERING'S PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL AND SOCIAL SUPPORT SERVICES TO PATIENTS, THEIR FAMILIES, AND CAREGIVERS. ALL MEDICAID OUTPATIENT VISITS AND INPATIENT ENCOUNTERS ARE SUBSIDIZED BY MEMORIAL SLOAN KETTERING, AS ARE UNREIMBURSED TIME AND EFFORT BY NURSES TO STAFF A SMOKING CESSATION CLINIC. APPROXIMATELY 1600 PATIENTS AGREED TO PARTICIPATE IN TREATMENT BY THE NURSING STAFF DURING 2014. PHILANTHROPIC FUNDS ARE USED TO SUPPORT A SIGNIFICANT NUMBER OF THE DEPARTMENT'S OVERALL CLINICAL AND TRAINING ACTIVITIES. THE INTEGRATIVE MEDICINE SERVICE PROVIDES FREE CLINICAL CARE FOR INPATIENTS. DURING 2014, THE SERVICE PROVIDED 8,008 TREATMENTS. THE CLINICAL SERVICES PROVIDED INCLUDE MUSIC THERAPY, TOUCH THERAPY, ACUPUNCTURE, YOGA AND YOGIC BREATHING, MEDITATION, GUIDED IMAGERY, KARATE, AND DANCE THERAPY. A TOUCH THERAPY FOR CAREGIVERS COURSE IS OFFERED FREE OF CHARGE TO ANY INPATIENT AND THEIR FAMILY MEMBERS ONCE PER MONTH. PART I, LINE 7, COLUMN (F): THE AMOUNT OF THE BAD DEBT EXPENSE REMOVED FROM THE 2014 CALCULATION IS $23,857,000. PART I, LINE 7: FINANCIAL ASSISTANCE REPRESENTS THE COST OF SERVICES PROVIDED TO PATIENTS WHO CANNOT AFFORD HEALTH CARE SERVICES DUE TO INADEQUATE RESOURCES AND/OR ARE UNINSURED OR UNDERINSURED. A PATIENT IS CLASSIFIED AS A FINANCIAL ASSISTANCE PATIENT IN ACCORDANCE WITH THE INSTITUTION'S ESTABLISHED POLICIES AND WHERE INSUFFICIENT PAYMENT FOR SUCH SERVICES IS ANTICIPATED. THE INSTITUTION CONSIDERS PATIENTS FOR FINANCIAL ASSISTANCE IF HOUSEHOLD INCOME IS LESS THAN 500% OF THE FEDERAL POVERTY GUIDELINES. SERVICES PROVIDED AS FINANCIAL ASSISTANCE ARE NOT REPORTED AS REVENUE. THE COSTS REPORTED ON LINE 7 WERE BASED ON VARIOUS SOURCES. FINANCIAL ASSISTANCE AND UNREIMBURSED MEDICAID AND MEDICARE COMMUNITY BENEFITS COST WERE BASED ON A COST TO CHARGE RATIO CALCULATION. THE TOTAL CHARGES ASSOCIATED WITH THESE PROGRAMS ARE MULTIPLIED BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. THE COSTS ASSOCIATED WITH A PORTION OF THE HEALTH PROFESSIONAL EDUCATION COMMUNITY BENEFIT ARE ALSO OBTAINED FROM THE STEP-DOWN OF COSTS PREPARED AS PART OF THE NYS INSTITUTIONAL COST REPORT. COST OF PROVIDING FINANCIAL ASSISTANCE AS CALCULATED PER THE ABOVE IS NET OF AMOUNTS RECEIVED FROM THE NYS BAD DEBT AND CHARITY CARE POOLS. TO ARRIVE AT THE AMOUNTS REPORTED ON THE TABLE ADDITIONAL STEPS AS OUTLINED BELOW WERE TAKEN. UNPAID COST OF GOVERNMENT SPONSORED HEALTH CARE REPRESENTS THE ESTIMATED DIFFERENCE BETWEEN THE PAYMENTS MADE UNDER THE MEDICARE AND MEDICAID PROGRAMS AND THE INSTITUTION'S COST OF PROVIDING THESE SERVICES AS CALCULATED ABOVE. THE INSTITUTION SUBTRACTS ALL REVENUES RECEIVED FROM THE MEDICARE AND MEDICAID PROGRAMS TO DETERMINE THE COMMUNITY BENEFIT PROVIDED. RESEARCH COMMUNITY BENEFIT COSTS REPRESENT ALL COSTS FOR BASIC TRANSLATIONAL AND CLINICAL RESEARCH, SUPPORTED BY INSTITUTIONAL FUNDS, GOVERNMENTAL, AND OTHER NON-PROFIT ORGANIZATIONS. RESEARCH COSTS SUPPORTED BY PHILANTHROPIC FUNDS, TOTALING $70M ARE NOT INCLUDED IN SCHEDULE H, PART I, LINE 7. THE INSTITUTION IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTION TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS, RADIOLOGY STUDENTS, NURSING STUDENTS, SOCIAL WORK STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER BIOLOGY. THE AMOUNTS REPORTED AS HEALTH TRAINING REPRESENT INSTITUTIONAL FUNDS, AS WELL AS COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. PART II: MSKCC ENGAGES IN AND SUPPORTS COALITION BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES THE INSTITUTION SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF MEMBERS SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE AMERICAN PUBLIC HEALTH ASSOCIATION, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR PARTICULAR TYPES OF CANCER. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. PART III, LINE 2: THE AMOUNT ON LINE 2 IS THE ACTUAL 2014 BAD DEBT WRITE-OFF WHICH IS DERIVED BY TAKING THE GROSS CHARGES ASSOCIATED WITH THE PROVISIONS FOR BAD DEBTS AND MULTIPLYING BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. A SEPARATE RATIO IS CALCULATED FOR EACH TYPE OF PATIENT CARE ACTIVITY: INPATIENT, OUTPATIENT AND PHYSICIAN. PART III, LINE 3: PATIENTS HAVE THE OPPORTUNITY TO PURSUE VARIOUS FINANCIAL ASSISTANCE PROGRAMS THROUGH MSKCC'S FINANCIAL ASSISTANCE PROGRAM. IF A PATIENT IS FOUND TO HAVE THE APPROPRIATE RESOURCES TO PAY FOR HEALTH SERVICES AND DOES NOT, OR CHOOSES NOT TO PARTICIPATE IN AVAILABLE HEALTH BENEFIT PROGRAMS THE COLLECTION PROCESS WILL BE PURSUED IN ACCORDANCE WITH THE INSTITUTION'S POLICY. ONCE DEEMED UNCOLLECTABLE, THE CHARGES ARE CLASSIFIED AS BAD DEBTS AND ARE CHARGED OFF AS SUCH. THE AMOUNTS REPORTED IN PART III, REFLECT THE COST OF THESE ACCOUNTS AS CALCULATED BASED ON THE COST-TO-CHARGE RATIO METHODOLOGY DESCRIBED EARLIER. IN DETERMINING THE AMOUNT THAT REASONABLY COULD BE ATTRIBUTABLE TO PATIENTS WHO LIKELY WOULD QUALIFY FOR FINANCIAL ASSISTANCE UNDER THE INSTITUTION'S POLICY, THE INSTITUTION REVIEWED THE CASES THAT WERE CLOSED WITH AN "INCOMPLETE" STATUS IN THE FINANCIAL ASSISTANCE PROGRAM FROM 2010 THROUGH 2014. THE INST true RALPH LAUREN CENTER FOR CANCER & PREVENTION 1919 MADISON AVENUE New York NY 10035 020597827 501(C)(3) 1000000 SUPPORT OPERATING COSTS 1 STIPENDS 2195 58153000 Form 990, Schedule I FOR THE YEAR 2014, THE AMOUNT IS FOR STIPENDS PAID TO 351 RESEARCH FELLOWS, 110 RESEARCH SCHOLARS, AND 60 GRADUATE SCHOOL STUDENTS. STIPENDS WERE ALSO PAID TO A TOTAL OF 1,674 CLINICAL INTERNS, RESIDENTS AND FELLOWS THAT FILLED 465 POSITIONS DURING THE YEAR. EDUCATION AND TRAINING INCLUDES CLASSROOM INSTRUCTION WITH HANDS-ON EXPERIENCE IN BOTH RESEARCH LABORATORIES AND CLINICAL CARE ACTIVITIES. THE AFOREMENTIONED GRANTEES ARE REQUIRED TO BE IN COMPLIANCE WITH ACADEMIC REQUIREMENTS. THIS INCLUDES DIRECT SUPERVISION AND DIRECTION BY PHYSICIANS AND RESEARCH INVESTIGATORS. RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION DURING 2014, MSKCC PAID $1,000,000 TO THE RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION TO OFFSET OPERATING EXPENSES. THE BOARD HAD APPROVED RESOLUTIONS TO SUPPORT THE RALPH LAUREN CENTER'S LOSSES UP TO $1,000,000 PER YEAR FROM 2014 - 2016. MSKCC REGULARY MEETS WITH THE RALPH LAUREN CENTER'S BOARD OF DIRECTORS TO REVIEW THAT THEIR SPENDING IS IN CONFORMITY WITH THEIR MISSION. X X true true X X X X X true true false false false false false true true true JOHN R GUNN CHIEF OPERATING OFFICER 1062632 0 771939 0 68828 0 39800 0 49706 0 1992905 0 19500 0 MICHAEL P GUTNICK EXECUTIVE VP & CFO 890632 0 606774 0 46800 0 39800 0 45407 0 1629413 0 19500 0 MARK SVENNINGSON SVP FINANCE & CONTROLLER 574398 0 126300 0 71729 0 39800 0 37637 0 849864 0 19500 ERIC M COTTINGTON PHD SVP RESEARCH & TECHNOLOGY MGMT 460915 0 227196 0 95431 0 39900 0 38502 0 861944 0 19500 THOMAS KELLY MD LAB MEMBER. FORMER SKI DIR 860251 0 0 0 49214 0 39800 0 44570 0 993835 0 19500 MAUREEN KILLACKEY DPIC MED DIR REGIONAL NETWORK 265161 0 0 0 0 0 0 0 9482 0 274643 0 JASON KLEIN SVP-CHIEF INVESTMENT OFFICER 847806 0 777857 0 28463 0 817657 0 37548 0 2509331 0 19500 EDWARD MAHONEY SVP FACILITIES MGMT & CONST 505966 0 246685 0 33582 0 39800 0 25540 0 851573 0 19500 KENNETH MARIANS PHD DEAN, GERSTNER GRADUATE SCHOOL 516543 0 0 0 25186 0 39800 0 34923 0 616452 0 19500 KATHRYN MARTIN EVP & HOSPITAL ADMINISTRATOR 864177 0 589734 0 49187 0 39800 0 38809 0 1581707 0 19500 ELLEN MILLER-SONET VP MARKETING 182945 0 0 0 0 0 0 0 29918 0 212863 0 RICHARD K NAUM SVP DEVELOPMENT 418165 0 205933 0 29811 0 37571 0 32373 0 723853 0 15686 ROGER PARKER ESQ EVP & GENERAL COUNSEL 440181 0 212700 0 28791 0 38976 0 11168 0 731816 0 17040 PATRICIA C SKARULIS SVP-CHIEF INFORMATION OFFICER 613282 0 297053 0 19500 0 39800 0 13159 0 982794 0 19500 GEORGE BOSL MD CHAIRMAN & ATTENDING MEDICINE 993520 0 25000 0 19500 0 39800 0 27004 0 1104824 0 19500 HEDVIG HRICAK MD CHAIRMAN & ATTENDING RADIOLOGY 1335135 0 0 0 144969 0 30300 0 44215 0 1554619 0 9750 ANNE MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 458538 0 764610 0 24825 0 30300 0 40006 0 1318279 0 9301 SIMON N POWELL MD CHAIR & ATTEND RAD ONCOLOGY 1485173 0 0 0 145407 0 30300 0 39968 0 1700848 0 9750 PETER T SCARDINO MD CHAIRMAN & ATTENDING SURGERY 1502606 0 525000 0 39468 0 34762 0 41644 0 2143480 0 9750 PETER G CORDEIRO MD CH ATTDG PLASTIC & RECONST 1524166 0 0 0 39899 0 30300 0 41666 0 1636031 0 9750 PHILIP GUTIN MD CHAIR & ATTENDING NEUROSURGERY 2721878 0 0 0 17705 0 30300 0 30454 0 2800337 0 10000 JOSEPH DISA MD ATTENDING PLASTIC SURGERY 1524567 0 0 0 42876 0 30300 0 41044 0 1638787 0 9750 CRAIG B THOMPSON MD PRESIDENT & CEO 1527183 0 886016 0 297446 0 39800 0 194481 0 2944926 0 19500 CAROLYN B LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 359502 0 70000 0 9191 0 25154 0 19727 0 483574 0 1360 JOSE BASELGA MD PHD PIC & CHIEF MEDICAL OFFICER 948091 0 601688 0 94752 0 39800 0 37303 0 1721634 0 19500 KERRY BESSEY SVP & CHIEF HR OFFICER 537867 0 263315 0 34611 0 39800 0 37065 0 912658 0 19500 MARK BILSKY MD ATTENDING-DEPT OF NEUROSURGERY 1758828 0 0 0 37094 0 30300 0 33996 0 1860218 0 9750 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 357273 0 175000 0 37096 0 23827 0 24719 0 617915 0 3740 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 301402 0 105000 0 8812 0 26069 0 25884 0 467167 0 RICHARD BARAKAT MD DPIC-REGIONAL CARE NETWORK 1128864 0 170000 0 68785 0 30300 0 40591 0 1438540 0 9750 PAUL SABBATINI MD DPIC CLINICAL RESEARCH 552170 0 100000 0 16430 0 30300 0 16131 0 715031 0 9750 MICHELLE BURKE VP PATIENT SUPPORT SERVICES 309559 0 49000 0 9507 0 25923 0 12788 0 406777 0 3411 ELIZABETH MCCORMICK MSNRN SVP & CH NURSING OFFICER 461386 0 112500 0 16615 0 39269 0 17016 0 646786 0 13390 CYNTHIA MCCOLLUM SVP HOSPITAL OPERATIONS 459200 0 112500 0 16615 0 39800 0 27178 0 655293 0 13390 MARGARET BURKE SVP AMBULATORY CARE-HOSP OPS 458988 0 150000 0 98166 0 39800 0 33845 0 780799 0 12218 CHARLES LUCARELLI DIRECTOR PHARMACY 277921 0 40000 0 3555 0 22115 0 35780 0 379371 0 672 JOAN MASSAGUE PHD DIRECTOR, SLOAN KETTERING INST 671597 0 0 0 100831 0 12800 0 14903 0 800131 0 DAVID JONES MD CHIEF ATTENDING THORACIC SURGY 1113308 0 310000 0 53245 0 30300 0 34081 0 1540934 0 3293 Supplemental Compensation Information SCHEDULE J, PART I, LINE 1A BUSINESS OR FIRST CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN 6 CONTINUOUS HOURS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. TRAVEL FUNDED BY FEDERAL GRANTS GENERALLY MAY NOT EXCEED COACH FARES. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATED. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH AND ENTERTAINMENT OF STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J,PART I, LINE 4A - INCLUDED IN FORM 990, PART VII SECTION A,LINE 4A IS SEVERANCE PAY AS FOLLOWS: MAUREEN KILLACKEY, FORMER DEPUTY PHYSICAN IN CHIEF, $266,860 ELLEN MILLER-SONET, FORMER VP MARKETING, $ 188,280 LINE 4B THE INSTITUTION MAINTAINS A NONQUALIFIED DEFERRED COMPENSATION PLAN WHICH IS USED FOR EMPLOYER CONTRIBUTIONS IN EXCESS OF THOSE ALLOWED BY THE RETIREMENT PLAN. LINE 7- INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. LINE 8 AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT SCHEDULE J, PART III GRANDFATHERED MSKCC DEFERRED COMPENSATION PLANS Included in Other Reportable Compensation are certain distributions from deferred compensation plans that the Institution maintains for certain management and HIGHLY COMPENSATED employees. These grandfathered plans were adopted in the early and mid-1980s and have been closed to new participants since August 16, 1986. The grandfathered plans allowed participants to irrevocably defer portions of their approved salary until certain conditions were met, typically retirement or disability. In addition, the Institution made contributions to the plans to the extent contributions to the MSKCC Retirement Plan for such participants were limited by applicable contribution limits under the Internal Revenue Code. The Institution provided participants with the opportunity to receive distributions as permitted under Section 409A of the Internal Revenue Code. This opportunity was exercised by numerous participants. These distributed amounts are reported as W-2 compensation. 100 percent of these amounts reflect the deferral of a portion of the participant's approved compensation package and related investment experience since the commencement of an individual's plan participation. As contributions were made to these plans for previous periods, the contribution amounts were reported on Form 990 for the applicable period as contributions to deferred compensation plans with respect to officers, key employees, and other highest paid employees. These amounts, as adjusted for investment experience, are reported again now on Form 990 as distributions from the plans. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 64983QS83 2006-06-29 102783274 SEE PART VI false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 64983QT25 2006-06-29 114610323 SEE PART VI false false false C DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649903B91 2008-05-13 456109226 SEE PART VI false false false D DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649906RK2 2012-02-16 388814944 SEE PART VI false false false A 0 0 112974138 0 0 0 1525106 0 0 111449032 0 0 2009 false false true true B 0 0 131322829 0 0 63319920 1762909 0 0 0 66240000 0 false true true true C 57515000 0 456110736 0 0 0 6109226 0 0 0 450001510 0 true false true true D 1700000 0 389779787 0 7803422 0 2651698 0 0 90399015 288925652 0 2014 false true true true A false false false true false 0.00000 0.00000 0.00000 false false false true B false false false true false 0.00000 0.00000 0.00000 false false false true C 0 D false false false true false 0 false false false true A false false false true false false 0 false 0 false true B false false false true false false 0 false 0 false true C false false false true false false 0 false 0 false true D false true false false false false 0 false 0 false true A true B true C true D true 1 PART I COL (F) DESCRIPTION OF PURPOSE: 2006 SERIES I BONDS CUSIP #64983QS83: THE 2006 SERIES I BONDS WERE USED TO CONSTRUCT A RESEARCH FACILITY AND RESIDENTIAL CONDOMINIUM. 2006 SERIES II BONDS CUSIP #64983QT25: 2006 SERIES II BONDS WERE USED TO ADVANCE REFUND A PORTION OF THE 2003 BONDS ISSUED ON MAY 14, 2003. 2008 SERIES BONDS CUSIP #649903B91: 2008 SERIES BONDS WERE USED TO CURRENT REFUND A PORTION OF THE 2002A BONDS ISSUED IN JANUARY 24, 2002. 2012 SERIES BONDS CUSIP 649906RK2: WERE USED TO CONSTRUCT AND EQUIP A NEW AMBULATORY CARE FACILITY AND ADVANCE REFUND THE 2003 BONDS ISSUED ON MAY 14, 2003. 2013 SERIES I BONDS CUSIP #6499053Z7: 2013 SERIES BONDS WERE USED TO CONSTRUCT A SURGICAL FACILITY. PART II LINE 3: THE AMOUNT OF PROCEEDS ON PART II LINE 3 IS DIFFERENT FROM PART I COLUMN (E) BECAUSE PART II LINE 3 INCLUDES INVESTMENT INCOME. PART III, LINE 3 (D) ANY RESEARCH AGREEMENTS THAT MAY RESULT IN PRIVATE BUSINESS USE OF BOND FINANCED PROPERTIES ARE REVIEWED FIRST BY IN-HOUSE STAFF WHO ARE KNOWLEDGEABLE AND RESPONSIBLE FOR THE FORM 990. OUTSIDE COUNSEL IS CONSULTED IF QUESTIONS ARISE. PART IV, LINE 2 (C ) THE 2006 SERIES I AND SERIES II BONDS REBATE COMPUTATIONS WERE PERFORMED ON JUNE 28, 2011. THE 2008 SERIES I AND SERIES II BONDS REBATE COMPUTATIONS WERE PERFORMED ON MAY 12, 2013. A DORMITORY AUTHORITY OF THE STATE OF NEW YORY 146000293 6499063Z7 2013-06-28 80000000 SEE PART VI false false false A 10000000 0 80216774 0 0 0 0 0 0 80216774 0 0 false false false A false false false false 0.00000 0.00000 0.00000 false false false true A false true false false false false 0 false 0 false true A true 2 Hedvig Hricak MD CHAIR-RADIOLOGY MORTGAGE X 700000 100000 false true true SIMON POWELL MD CHAIR-RAD ONCOLOGY MORTGAGE X 1000000 800000 false true true RICHARD BARAKAT MD DEP PHY IN CHIEF MORGTAGE X 500000 500000 false true true 1400000 PERKINS EASTMAN SEE PART V 10521896 ARCHITECTUAL SERVICES false MS T LINDSTEN SEE PART V 172262 FAMILY EMPLOYMENT false MR I GUTNICK SEE PART V 99526 FAMILY EMPLOYMENT false KING STREET CAPITAL MANAGEMENT SEE PART V 693875 INVESTMENT MANAGEMENT FEES false MR L SELBY SEE PART V 66615 FAMILY EMPLOYMENT false BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS 1. MR. STEPHEN FRIEDMAN IS A BOARD MEMBER OF THE INSTITUTION. THE INSTITUTION PURCHASED ARCHITECTURAL SERVICES FROM THE FIRM OF PERKINS/EASTMAN. THE TOTAL AMOUNT PAID IN 2014 WAS $10,521,896. MR. PERKINS AND MR. FRIEDMAN ARE BROTHERS-IN-LAW. 2. DR. THOMPSON IS THE PRESIDENT OF THE INSTITUTE. HIS SPOUSE IS A LABORATORY MEMBER IN SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH. HER COMPENSATION FOR 2014 WAS $172,262. 3. MR. MICHAEL P. GUTNICK IS THE EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER. HIS SON IS A FUND COORDINATOR IN THE DIVISION OF MEDICINE. HIS SON'S TOTAL COMPENSATION FOR 2014 WAS $99,526. 4. MS. JAMIE NICHOLLS IS A BOARD MEMBER OF THE INSTITUTION. HER SPOUSE IS A CO-FOUNDER OF KING STREET CAPITAL MANAGEMENT. DURING 2014, THE INSTITUTION PAID KING STREET $693,875 IN MANAGEMENT FEES. THE INVESTMENT AGREEMENT CALLS FOR CARRIED INTEREST THAT IS NORMAL AND CUSTOMARY IN THE COURSE OF INVESTING IN ALTERNATIVE INVESTMENTS. 5. MR. NORMAN C. SELBY IS A BOARD MEMBER WITHIN THE ORGANIZATION. HIS SON IS A RESEARCH FELLOW IN THE DEPARTMENT OF SURGERY. HIS SON'S TOTAL COMPENSATION FOR 2014 WAS $66,615. THE INDIVIDUALS LISTED WERE NOT A PARTY TO THE TRANSACTIONS. THERE IS NO SHARING OF THE INSTITUTION'S REVENUE. THE PURCHASES OF GOODS OR SERVICES BY THE INSTITUTION WERE MADE IN THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS, AT COMMERCIALLY AVAILABLE RATES NORMALLY CHARGED TO REGULAR CUSTOMERS. X 1400020 THRIFT VALUE X 78 4862695 MARKET VALUE false true false PART I EXCLUDED FROM THIS VALUE ARE PLEDGE PAYMENTS, MADE BY STOCK, TOTALING $2,733,879. PROMISES TO GIVE ARE REPORTED AT THE DATE THE INTENT IS MADE IN WRITING. PART I CLOTHING AND HOUSEHOLD GOODS ARE DONATED AT OUR THRIFT SHOP. THE SOCIETY OF MSKCC RUNS THE THRIFT SHOP FOR THE BENEFIT OF THE ORGANIZATION. PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. IRS 990 PART VI, SECTION A LINES 6-7 The Articles of incorporation and By-Laws were reviewed to determine that the supported organizations outlined in Schedule-A have the power to elect or appoint board members over the supporting organizations. Additionally Memorial Sloan-Kettering Cancer Center EIN 13-1924236, MSK, is the single member of the Prostate Cancer Clinical Trials Consortium LLC, PCCTC, who has elected to be treated as a disregarded entity of MSK for tax purposes. Memorial Hospital for Cancer and Allied Diseases EIN 13-1624082 is the single member of MSKCC Properties LLC, who has elected to be treated as a corporation for tax purposes. PART VI, LINE 11B PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE CONTROLLER AND THE CHIEF FINANCIAL OFFICER. IT IS THEN REVIEWED BY THE JOINT AUDIT COMMITTEE OF THE BOARD. THE JOINT AUDIT COMMITTEE REFERS THE FORM 990 TO THE FULL BOARD, AND A COPY IS PROVIDED TO EACH BOARD MEMBER FOR FURTHER REVIEW. MEMORIAL SLOAN-KETTERING'S FORM 990 IS REVIEWED BY OUTSIDE COUNSEL AND IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. FORM 990, PART VI, LINE 12C PROCESS USED TO MONITOR COMPLIANCE THE COMPLIANCE OFFICER AND STAFF ARE RESPONSIBLE FOR ADMINISTERING THE CONFLICT OF INTEREST PROGRAM--INCLUDING THE IMPLEMENTATION OF THE POLICY--BY MAINTAINING PROCESSES FOR DISCLOSURE OF OUTSIDE ACTIVITIES AND FOR THE TIMELY REVIEW OF REPORTED INTERESTS, INCLUDING: 1. MANAGEMENT OF THE ANNUAL DISCLOSURE CERTIFICATION PROCESS AND THE PROCESS BY WHICH COVERED PERSONS DISCLOSE AT TIME OF HIRE. COVERED PERSONS RECEIVE AN ANNUAL QUESTIONNAIRE REQUESTING DISCLOSURE OF RELATIONSHIPS AND TRANSACTIONS THAT MIGHT INVOLVE A CONFLICT OF INTEREST. QUESTIONNAIRE RESPONSES ARE REVIEWED BY THE COMPLIANCE OFFICER AND STAFF. FOLLOW-UP INQUIRIES ARE MADE IF NEEDED. MATTERS ARE SUBMITTED TO AN INTERNAL MANAGEMENT COMMITTEE AND A COMMITTEE OF THE BOARD OF MANAGERS IF ADJUDICATION IS NEEDED. 2. REVIEW AND ADJUDICATION OF OUTSIDE ACTIVITIES THAT REQUIRE PRE- APPROVAL OR DISCLOSURE; FACILITATION OF A REVIEW BY THE OFFICE OF INDUSTRIAL AFFAIRS OF ANY OUTSIDE ACTIVITIES THAT INVOLVE INTELLECTUAL PROPERTY OR OTHERWISE INVOLVE AN ACTIVITY IN WHICH THE CENTER'S RIGHTS MAY REQUIRE PROTECTION. 3. ADMINISTRATION OF CONFLICT OF INTEREST ADVISORY COMMITTEE MEETINGS, INCLUDING DEVELOPMENT AND DISTRIBUTION OF AGENDAS AND SUPPORTING DOCUMENTS, DRAFTING AND DISTRIBUTION OF MINUTES, AND MAINTENANCE OF COMMITTEE RECORDS. 4. DOCUMENTATION OF THE OUTCOME OF ALL REVIEWS OF REPORTED OUTSIDE ACTIVITIES. COMMUNICATION TO THE COVERED PERSON OF THE OUTCOME OF ALL REVIEWS, INCLUDING DOCUMENTATION OF MANAGEMENT PLANS. AS PART OF THE CLINICAL RESEARCH REVIEW PROCESS, QUESTIONS ON THE PROTOCOL SUBMISSION FORM ARE DESIGNED TO ELICIT INFORMATION ABOUT POTENTIAL CONFLICTS. SITUATIONS IN WHICH A STAFF PARTICIPANT IN RESEARCH REPORTS A POTENTIAL CONFLICT ARE REFERRED TO THE CHAIR OF THE COIAC AND TO THE COMPLIANCE OFFICER FOR REVIEW. THE BOARD OF MEMORIAL SLOAN-KETTERING CANCER CENTER HAS MEMBERS THAT ACTIVELY SERVE AS OFFICERS AND/OR BOARD MEMBERS OF PUBLICLY-TRADED COMPANIES. THE INSTITUTION MAY PROCURE GOODS AND/OR SERVICES FROM THESE PUBLICLY TRADED COMPANIES THROUGH THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS ON TERMS AND CONDITIONS WHICH ARE THE SAME THAT SUCH COMPANIES CHARGE TO THE GENERAL PUBLIC. ANY OF OUR BOARD MEMBERS THAT HAVE AN AFFILIATION WITH SUCH COMPANIES ARE NOT INVOLVED IN THE TRANSACTION, INCLUDING, WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, IN NEGOTIATING OR AFFECTING THE TERMS OF THE TRANSACTION. THE INSTITUTION HAS A COMPREHENSIVE CONFLICT OF INTEREST POLICY. REPORTABLE TRANSACTIONS IDENTIFIED THROUGH OUR ANNUAL CONFLICT OF INTEREST QUESTIONNAIRE ARE DISCLOSED ON SCHEDULE L. THESE TRANSACTIONS WERE ALSO CONSUMMATED ON AN ARM'S LENGTH BASIS BY MANAGEMENT OF THE INSTITUTION. MSKCC'S "POLICY ON CONFLICTS OF INTERESTS FOR DIRECTORS AND KEY EMPLOYEES" APPLIES TO ANY BOARD OF MANAGERS MEMBER, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD-DELEGATED POWERS. INDIVIDUALS COVERED BY THIS POLICY HAVE A DUTY TO DISCLOSE FINANCIAL INTERESTS, AS DEFINED BY THE POLICY, ANNUALLY AND AS THEY ARISE. IN THE EVENT A COVERED INDIVIDUAL IS INVOLVED IN A BOARD OR COMMITTEE ACTION (SUCH AS APPROVAL OF A TRANSACTION OR ARRANGEMENT) AND THE INDIVIDUAL HAS A FINANCIAL INTEREST RELATED TO THE MATTER BEFORE THE BOARD, THE INDIVIDUAL MUST DISCLOSE THE FINANCIAL INTEREST AND ALL MATERIAL FACTS TO THE BOARD OR COMMITTEE. THE INDIVIDUAL MUST LEAVE THE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON, AND THE REMAINING, DISINTERESTED BOARD OR COMMITTEE MEMBERS ARE RESPONSIBLE TO DECIDE IF A CONFLICT EXISTS. IF A DETERMINATION IS MADE THAT A CONFLICT EXISTS, THE INVOLVED INDIVIDUAL MAY MAKE A PRESENTATION TO THE BOARD OR COMMITTEE BUT S/HE MUST LEAVE THE MEETING DURING THE DISCUSSION OF AND THE VOTE ON THE TRANSACTION OR ARRANGEMENT. THE BOARD OR COMMITTEE IS REQUIRED TO DETERMINE WHETHER MSKCC CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS FROM AN UNCONFLICTED PERSON OR ENTITY. AS APPROPRIATE, THE CHAIRPERSON OF THE BOARD OR COMMITTEE IS RESPONSIBLE TO APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. FORM 990, PART VI, LINE 15 PROCESS FOR DETERMINING COMPENSATION MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC) IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE MSKCC BOARD OF OVERSEERS AND MANAGERS HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED ENTIRELY OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARDS TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS DECEMBER 2014. THIS REVIEW SETS THE COMPENSATION FOR THE FOLLOWING YEAR. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC, AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. ON AN ANNUAL BASIS, THE COMMITTEE PROVIDES THE FULL BOARD WITH AN OVERVIEW OF ITS DETERMINATIONS AND PROCESS. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. - THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. FORM 990, PART VI LINE 19 OUR AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS CAN BE ACCESSED AT THE FOLLOWING WEB ADDRESS: WWW.DACBOND.COM. THE INSTITUTION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. THE INFORMATION AVAILABLE ON THIS WEB SITE INCLUDES AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS AND THE BOND OFFERING STATEMENTS FOR ALL OUR DEBT ISSUES. IN ADDI PROSTATE CANCER CLINICAL TRIALS 1275 YORK AVE NEW YORK NY 10065 352506225 CANCER CARE DE 2003000 840000 MSKCC RALPH LAUREN CTR FOR CANCER & PREVENTION 1919 MADISON AVE NEW YORK NY 10036 020597827 CANCER CARE NY 501( C)3 9 MSKCC true MEMORIAL MEDICAL CARE PC 1275 YORK AVENUE NEW YORK NY 10065 352491455 CANCER CARE NY 501 (C )3 9 MSKCC true MEM CRITICAL CARE 1275 YORK AVE NY NY 10065 133348785 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM INFECT DISEASE 1275 YORK AVE NY NY 10065 133278582 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM MEDICAL CONSULT 1275 YORK AVE NY NY 10065 133278550 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NUTRITION GRP 1275 YORK AVE NY NY 10065 133278576 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM SOLID TUMOR GRP 1275 YORK AVE NY NY 10065 133278578 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PULMONARY FUNC 1275 YORK AVE NY NY 10065 133304834 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CARDIOPULMONARY 1275 YORK AVE NY NY 10065 133278552 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK RADIOLOGY GRP 1275 YORK AVE NY NY 10065 133375559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NUCLEAR MED 1275 YORK AVE NY NY 10065 133278580 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM RADIATION ONCOL 1275 YORK AVE NY NY 10065 133237927 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PATHOLOGY GRP 1275 YORK AVE NY NY 10065 133365998 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ANESTHESIOLOGY 1275 YORK AVE NY NY 10065 133367135 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PEDIATRICS GRP 1275 YORK AVE NY NY 10065 133346908 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROLOGY GRP 1275 YORK AVE NY NY 10065 133399377 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PSYCHIATRY GRP 1275 YORK AVE NY NY 10065 133430629 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK AT GUTTMAN 1275 YORK AVE NY NY 10065 133875002 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK PHYS AT PHELPS 1275 YORK AVE NY NY 10065 133897156 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK AT MERCY 1275 YORK AVE NY NY 10065 133954858 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK PHYS-ST CLARE'S 1275 YORK AVE NY NY 10065 133897154 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK REHABILITATION 1275 YORK AVE NY NY 10065 134010371 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK SURGERY GROUP 1275 YORK AVE NY NY 10065 134010372 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK HAUPPAUGE 1275 YORK AVE NY NY 10065 134059247 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROSURGERY 1275 YORK AVE NY NY 10065 133251621 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 INTERGRATIVE MED 1275 YORK AVE NY NY 10065 542092060 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK-REGIONAL NETWK 1275 YORK AVE NY NY 10065 020594889 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK BASKING RIDGE 1275 YORK AVE NY NY 10065 593801080 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM URGENT CARE GRP 1275 YORK AVE NY NY 10065 651263291 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLN GENETICS 1275 YORK AVE NY NY 10065 651263292 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DEVELOP CHEMO 1275 YORK AVE NY NY 10065 133278548 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK CLINIC PRACTICE 1275 YORK AVE NY NY 10065 510616510 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM BREAST GROUP 1275 YORK AVE NY NY 10065 562568640 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM COLORECTAL GRP 1275 YORK AVE NY NY 10065 562568642 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DENTAL GRP 1275 YORK AVE NY NY 10065 562568630 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLINICAL IMMUNO 1275 YORK AVE NY NY 10065 133278559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM GASTRIC MIX TMR 1275 YORK AVE NY NY 10065 562568650 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM GYNECOLOGY GRP 1275 YORK AVE NY NY 10065 562568655 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEAD & NECK GRP 1275 YORK AVE NY NY 10065 562568656 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEPATOBILIARY 1275 YORK AVE NY NY 10065 562568667 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROSURGERY 1275 YORK AVE NY NY 10065 562568663 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPT ABRAMSON 1275 YORK AVE NY NY 10065 562568627 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPTHALMIC ONOCO 1275 YORK AVE NY NY 10065 562568675 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPHTHALMOLOGY 1275 YORK AVE NY NY 10065 562568669 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ORTHOPEDIC GRP 1275 YORK AVE NY NY 10065 562568680 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PEDIATRIC SURG 1275 YORK AVE NY NY 10065 562568683 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLINICAL PHY 1275 YORK AVE NY NY 10065 133278556 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PLASTIC RECON 1275 YORK AVE NY NY 10065 562568623 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM THORACIC GRP 1275 YORK AVE NY NY 10065 562568677 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM UROLOGY GRP 1275 YORK AVE NY NY 10065 562568638 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PAIN SERVICE 1275 YORK AVE NY NY 10065 651283822 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DERMATOLOGY GRP 1275 YORK AVE NY NY 10065 133278581 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ENDOCRINE GRP 1275 YORK AVE NY NY 10065 133278583 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 GASTROENTEROLOGY 1275 YORK AVE NY NY 10065 133278574 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEMATOLOGYLYMP 1275 YORK AVE NY NY 10065 133278575 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 CHARITABLE REMAINDER TRUSTS 216 false true false false false false false false true true true true false false false true false false MEMORIAL SLOAN-KETTERING CANCER CENTER L 422938000 COST MEMORIAL SLOAN-KETTERING CANCER CENTER K 15892000 COST MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE L 46191000 COST MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE K 376991000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH L 16690000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH K 123637000 COST SKI REALTY INC J 13324000 COST SKI REALTY INC L 1936000 COST LOUIS V GERSTNER JR GRADUATE SCHOOL M 435000 COST RALPH LAUREN CTR FOR CANCER & PREVENTION Q 2723766 COST RALPH LAUREN CTR FOR CANCER & PREVENTION B 1000000 COST PROSTATE CANCER CLINICAL TRIALS M 262000 COST